DSIP (Delta Sleep Inducing Peptide)
DSIP (Delta Sleep Inducing Peptide) is a naturally occurring brain peptide first isolated from rabbit brain tissue. Research focuses on sleep promotion, stress reduction, and hormone regulation. It shows complex effects that vary depending on the context.
Verified sources for DSIP (Delta Sleep Inducing Peptide)
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of DSIP (Delta Sleep Inducing Peptide)
Proposed to modulate GABA, somatostatin, and circadian systems to promote deep sleep and reduce stress responses.
Proposed to promote delta (slow-wave) sleep, the deepest and most restorative sleep phase.
Effects appear context-dependent, which may normalize rather than simply induce sleep.
Proposed effects on circadian rhythm normalization, potentially useful for jet lag or shift work.
May modulate hypothalamic-pituitary-adrenal axis (proposed), reducing stress hormone release and cortisol levels.
Interacts with somatostatin, GABA, and opioid systems, which may influence GH, LH, and ACTH secretion.
Some studies suggest pain-modulating effects (proposed), possibly through enkephalin system interactions
Read Full DSIP (Delta Sleep Inducing Peptide) Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Cognition, Mood & Neuroprotection
UPDATE: FDA Picks 7 Peptides for July 2026 Reclassification Vote
The FDA will vote on reclassifying BPC-157, TB-500, KPV, MOTS-c, DSIP, Epitalon, and Semax for pharmacy compounding at the July 23-24 PCAC meeting.
Peptide Therapy for Sleep Optimization: The Quiet Trend Reshaping Recovery in 2026
Peptide therapy is quietly becoming the most promising frontier in sleep science. From DSIP to growth hormone secretagogues, here's how peptides are being studied for deep sleep and recovery.
RFK Jr. Says 14 Peptides Are Coming Back: Ban Reversal
HHS Secretary RFK Jr. told Joe Rogan that ~14 peptides banned by the FDA in 2023 will return to Category 1, restoring legal compounding access.